Temple University School of Pharmacy, Philadelphia, Pennsylvania
Loma Linda University School of Pharmacy, Loma Linda, California.
Am J Pharm Educ. 2023 Apr;87(4):ajpe9112. doi: 10.5688/ajpe9112. Epub 2022 Nov 14.
Although pharmacists improve outcomes in the care of patients with kidney diseases and current guidelines advocate multidisciplinary care, pharmacist nephrology training is not well described. This study seeks to characterize required and elective coursework within US Doctor of Pharmacy curricula. This information will be valuable in identification and evaluation of educational gaps for pharmacists as best practices in the education and care of kidney diseases for pharmacists are established. This prospective, cross-sectional, descriptive study assessed current practices and trends in education on kidney diseases within Doctor of Pharmacy curricula at accredited programs in the United States through an electronic survey. Forty-three percent (N=61) of all ACPE-accredited pharmacy institutions were represented in the survey. Content on kidney diseases was found to be taught in both required and elective coursework, and one-third of responding institutions offered advanced pharmacy practice experiences focused on kidney diseases. Variation was found in the amount of time allotted for the teaching of kidney diseases topics in pharmacy curricula and the types of experiential training offered. Six respondents reported offering postgraduate education that focused on kidney diseases. Most respondents were clinical faculty who had completed residency training and board certification. Given the complex interplay between kidney diseases and other health conditions, the increasing incidence and prevalence of kidney diseases, and the potential expansion of pharmacists' roles in the care of patients with kidney diseases, a review of current Doctor of Pharmacy curricula is necessary to guide any future optimization efforts to ensure practice-ready pharmacists.
尽管药剂师可以改善肾脏病患者的治疗效果,且现行指南提倡多学科护理,但药剂师肾病学培训的情况仍描述不足。本研究旨在描述美国药学博士课程中的必修和选修课程。这些信息对于确定和评估药剂师的教育差距非常有价值,因为随着为药剂师制定肾脏病教育和护理的最佳实践,药师在肾脏病教育和护理方面的最佳实践也在不断发展。本前瞻性、横断面、描述性研究通过电子调查评估了美国认可项目中药学博士课程中肾脏病教育的当前实践和趋势。该调查涵盖了全美 43%(N=61)的 ACPE 认可的药学机构。肾脏病的内容被发现既在必修课程中教授,也在选修课程中教授,三分之一的参与机构提供了专注于肾脏病的高级药学实践经验。药学课程中教授肾脏病主题的时间和提供的体验式培训类型存在差异。有 6 名受访者报告提供专注于肾脏病的研究生教育。大多数受访者是完成了住院医师培训和专科认证的临床教师。鉴于肾脏病与其他健康状况之间的复杂相互作用、肾脏病的发病率和患病率不断上升以及药剂师在肾脏病患者护理中的作用可能扩大,有必要对当前的药学博士课程进行审查,以指导任何未来的优化工作,确保药剂师具备实践能力。